Gilead files COVID-19 drug remdesivir with FDA
pharmaphorum
AUGUST 10, 2020
It also includes the phase 3 randomised, placebo-controlled study of Veklury conducted by the National Institute of Allergy and Infectious Diseases (NIAID). Under the terms of the agreement Pfizer will become one of several external partners who manufacture the investigational treatment for the disease.
90 
Let's personalize your content